325 related articles for article (PubMed ID: 28882452)
21. Enhanced CNS transduction from AAV.PHP.eB infusion into the cisterna magna of older adult rats compared to AAV9.
Chatterjee D; Marmion DJ; McBride JL; Manfredsson FP; Butler D; Messer A; Kordower JH
Gene Ther; 2022 Jun; 29(6):390-397. PubMed ID: 33753910
[TBL] [Abstract][Full Text] [Related]
22. Neonatal AAV delivery of alpha-synuclein induces pathology in the adult mouse brain.
Delenclos M; Faroqi AH; Yue M; Kurti A; Castanedes-Casey M; Rousseau L; Phillips V; Dickson DW; Fryer JD; McLean PJ
Acta Neuropathol Commun; 2017 Jun; 5(1):51. PubMed ID: 28645308
[TBL] [Abstract][Full Text] [Related]
23. Use of CRISPR/Cas9-mediated disruption of CNS cell type genes to profile transduction of AAV by neonatal intracerebroventricular delivery in mice.
Torregrosa T; Lehman S; Hana S; Marsh G; Xu S; Koszka K; Mastrangelo N; McCampbell A; Henderson CE; Lo SC
Gene Ther; 2021 Aug; 28(7-8):456-468. PubMed ID: 33612827
[TBL] [Abstract][Full Text] [Related]
24. CNS expression of glucocerebrosidase corrects alpha-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy.
Sardi SP; Clarke J; Kinnecom C; Tamsett TJ; Li L; Stanek LM; Passini MA; Grabowski GA; Schlossmacher MG; Sidman RL; Cheng SH; Shihabuddin LS
Proc Natl Acad Sci U S A; 2011 Jul; 108(29):12101-6. PubMed ID: 21730160
[TBL] [Abstract][Full Text] [Related]
25. Noninvasive delivery of an α-synuclein gene silencing vector with magnetic resonance-guided focused ultrasound.
Xhima K; Nabbouh F; Hynynen K; Aubert I; Tandon A
Mov Disord; 2018 Oct; 33(10):1567-1579. PubMed ID: 30264465
[TBL] [Abstract][Full Text] [Related]
26. The Neurotropic Properties of AAV-PHP.B Are Limited to C57BL/6J Mice.
Hordeaux J; Wang Q; Katz N; Buza EL; Bell P; Wilson JM
Mol Ther; 2018 Mar; 26(3):664-668. PubMed ID: 29428298
[TBL] [Abstract][Full Text] [Related]
27. Pronounced Therapeutic Benefit of a Single Bidirectional AAV Vector Administered Systemically in Sandhoff Mice.
Lahey HG; Webber CJ; Golebiowski D; Izzo CM; Horn E; Taghian T; Rodriguez P; Batista AR; Ellis LE; Hwang M; Martin DR; Gray-Edwards H; Sena-Esteves M
Mol Ther; 2020 Oct; 28(10):2150-2160. PubMed ID: 32592687
[TBL] [Abstract][Full Text] [Related]
28. D409H GBA1 mutation accelerates the progression of pathology in A53T α-synuclein transgenic mouse model.
Kim D; Hwang H; Choi S; Kwon SH; Lee S; Park JH; Kim S; Ko HS
Acta Neuropathol Commun; 2018 Apr; 6(1):32. PubMed ID: 29703245
[TBL] [Abstract][Full Text] [Related]
29. Comparative study of neuron-specific promoters in mouse brain transduced by intravenously administered AAV-PHP.eB.
Radhiyanti PT; Konno A; Matsuzaki Y; Hirai H
Neurosci Lett; 2021 Jun; 756():135956. PubMed ID: 33989730
[TBL] [Abstract][Full Text] [Related]
30. In Vivo Selection Yields AAV-B1 Capsid for Central Nervous System and Muscle Gene Therapy.
Choudhury SR; Fitzpatrick Z; Harris AF; Maitland SA; Ferreira JS; Zhang Y; Ma S; Sharma RB; Gray-Edwards HL; Johnson JA; Johnson AK; Alonso LC; Punzo C; Wagner KR; Maguire CA; Kotin RM; Martin DR; Sena-Esteves M
Mol Ther; 2016 Aug; 24(7):1247-57. PubMed ID: 27117222
[TBL] [Abstract][Full Text] [Related]
31. Transduction of the central nervous system after intracerebroventricular injection of adeno-associated viral vectors in neonatal and juvenile mice.
Gholizadeh S; Tharmalingam S; Macaldaz ME; Hampson DR
Hum Gene Ther Methods; 2013 Aug; 24(4):205-13. PubMed ID: 23808551
[TBL] [Abstract][Full Text] [Related]
32. Engineering viral vectors for acoustically targeted gene delivery.
Li HR; Harb M; Heath JE; Trippett JS; Shapiro MG; Szablowski JO
Nat Commun; 2024 Jun; 15(1):4924. PubMed ID: 38858354
[TBL] [Abstract][Full Text] [Related]
33. Administration of AAV-Alpha Synuclein NAC Antibody Improves Locomotor Behavior in Rats Overexpressing Alpha Synuclein.
Chen YH; Wu KJ; Hsieh W; Harvey BK; Hoffer BJ; Wang Y; Yu SJ
Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34205689
[TBL] [Abstract][Full Text] [Related]
34. Intracerebroventricular Administration of AAV9-PHP.B SYN1-EmGFP Induces Widespread Transgene Expression in the Mouse and Monkey Central Nervous System.
Galvan A; Petkau TL; Hill AM; Korecki AJ; Lu G; Choi D; Rahman K; Simpson EM; Leavitt BR; Smith Y
Hum Gene Ther; 2021 Jun; 32(11-12):599-615. PubMed ID: 33860682
[TBL] [Abstract][Full Text] [Related]
35. How can rAAV-α-synuclein and the fibril α-synuclein models advance our understanding of Parkinson's disease?
Volpicelli-Daley LA; Kirik D; Stoyka LE; Standaert DG; Harms AS
J Neurochem; 2016 Oct; 139 Suppl 1(Suppl 1):131-155. PubMed ID: 27018978
[TBL] [Abstract][Full Text] [Related]
36. Mutant GBA1 expression and synucleinopathy risk: first insights from cellular and mouse models.
Sardi SP; Singh P; Cheng SH; Shihabuddin LS; Schlossmacher MG
Neurodegener Dis; 2012; 10(1-4):195-202. PubMed ID: 22327140
[TBL] [Abstract][Full Text] [Related]
37.
Marcó S; Haurigot V; Bosch F
Hum Gene Ther; 2019 Oct; 30(10):1211-1221. PubMed ID: 31482754
[TBL] [Abstract][Full Text] [Related]
38. Widespread Central Nervous System Gene Transfer and Silencing After Systemic Delivery of Novel AAV-AS Vector.
Choudhury SR; Harris AF; Cabral DJ; Keeler AM; Sapp E; Ferreira JS; Gray-Edwards HL; Johnson JA; Johnson AK; Su Q; Stoica L; DiFiglia M; Aronin N; Martin DR; Gao G; Sena-Esteves M
Mol Ther; 2016 Apr; 24(4):726-35. PubMed ID: 26708003
[TBL] [Abstract][Full Text] [Related]
39. Efficient whole brain transduction by systemic infusion of minimally purified AAV-PHP.eB.
Konno A; Hirai H
J Neurosci Methods; 2020 Dec; 346():108914. PubMed ID: 32810474
[TBL] [Abstract][Full Text] [Related]
40. Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons.
Decressac M; Mattsson B; Lundblad M; Weikop P; Björklund A
Neurobiol Dis; 2012 Mar; 45(3):939-53. PubMed ID: 22182688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
